Christian Obah, MD
Anesthesiology · Kaysville, UTNPI 1912959008
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 188 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $785 and has fallen 68.1% since, to $251 in 2025. Among anesthesiology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 188 payments — averaging $19.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$633
- Collegium Pharmaceutical, Inc.$419
- Lundbeck LLC$254
- Indivior Inc.$216
- Teva Pharmaceuticals USA, Inc.$216
- Pfizer$215
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,740100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $633 |
| Collegium Pharmaceutical, Inc. | 28 | $419 |
| Lundbeck LLC | 14 | $254 |
| Indivior Inc. | 10 | $216 |
| Teva Pharmaceuticals USA, Inc. | 15 | $216 |
| Pfizer | 12 | $215 |
| Abbott | 2 | $212 |
| Si-bone, Inc. | 3 | $167 |
| Stimwave Technologies Incorporated | 1 | $109 |
| Curonix LLC | 1 | $98 |
| Lilly USA, LLC | 7 | $93 |
| Virtus Pharmaceuticals LLC | 6 | $84 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $79 |
| Biohaven Pharmaceuticals, Inc. | 4 | $74 |
| Almatica Pharma LLC | 3 | $72 |
| Arbor Pharmaceuticals, Inc. | 4 | $66 |
| Medtronic(2 entities) | 2 | $65 |
| Amgen | 3 | $63 |
| Nevro Corp. | 2 | $63 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $61 |
| Idorsia Pharmaceuticals US Inc | 3 | $50 |
| Biodelivery Sciences International, Inc. | 4 | $47 |
| Johnson & Johnson | 3 | $41 |
| Daiichi Sankyo Inc. | 2 | $40 |
| Kaleo, Inc. | 3 | $40 |
| Merck | 3 | $38 |
| Redhill Biopharma Inc. | 3 | $38 |
| Eisai Inc. | 2 | $36 |
| GRT US Holding, Inc. | 2 | $34 |
| Jazz Pharmaceuticals Inc. | 2 | $26 |
| Pacira Therapeutics, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Averitas Pharma Inc. | 1 | $20 |
| SPR Therapeutics, Inc | 1 | $12 |
| MDD US Operations, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ETERNA$194
How this compares
$3,740 in reported general payments places this provider in the 95th percentile of 510 anesthesiology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 23 | $23,646 |
| GraliseGabapentin | 13 | $11,784 |
| Oxymorphone Hcl ErOxymorphone Hcl | 14 | $9,994 |
| Oxycodone Hcl | 275 | $9,482 |
| Xtampza ErOxycodone Myristate | 15 | $9,023 |
| LinzessLinaclotide | 13 | $6,609 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 20 | $5,140 |
| Morphine Sulfate ErMorphine Sulfate | 104 | $3,794 |
| Lidocaine | 30 | $2,549 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 77 | $2,206 |
| Buprenorphine Hcl | 24 | $1,775 |
| Diclofenac Sodium | 25 | $1,738 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 49 | $1,724 |
| Morphine Sulfate | 39 | $1,285 |
| Gabapentin | 58 | $1,103 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCGralise | $72 | $11,78413 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $419 | $9,02315 claims |
| AbbVieLinzess | $633 | $6,60913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 510 anesthesiology providers in Utah.
Other anesthesiology in Kaysville
- Shane BroganSalt Lake City$104K
- Reed NelsonSt. George$45K
- Massimiliano Romanelli-GobbiMurray$25K
- Nathaniel BirgenheierSalt Lake City$24K
- Mark HuffMurray$16K
- Zachary JergensenSalt Lake City$16K
- Kenward JohnsonSalt Lake City$15K
- Devin ReedMidvale$13K
- John SummersMurray$13K
- Sheldon FurstSalt Lake City$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.